Search results
Results from the WOW.Com Content Network
The Rescue Diver course is the third level qualification in the American international system, [clarification needed] following the Advanced Open Water Diver qualification (AOWD). Historically the course was treated as a separate "speciality" rather than a mainstream certification in itself (and arguably it still is in many organization's ...
Charles Bowers Momsen (June 21, 1896 – May 25, 1967), nicknamed "Swede", was born in Flushing, New York. [1] He was an American pioneer in submarine rescue for the United States Navy, and he invented the underwater escape device later called the "Momsen lung", for which he received the Navy Distinguished Service Medal in 1929. [1]
Mometasone, also known as mometasone furoate, is a steroid (specifically, a glucocorticoid) medication used to treat certain skin conditions, hay fever, and asthma. [ 10 ] [ 11 ] [ 12 ] Specifically it is used to prevent rather than treat asthma attacks. [ 10 ]
Diver rescue, usually following an accident, is the process of avoiding or limiting further exposure to diving hazards and bringing a diver to a place of safety. [1] A safe place generally means a place where the diver cannot drown , such as a boat or dry land, where first aid can be administered and from which professional medical treatment ...
For treating atopic dermatitis, newer (second generation) corticosteroids, such as fluticasone propionate and mometasone furoate, are more effective and safer than older ones. They are also generally safe and do not cause skin thinning when used intermittently to treat atopic dermatitis flare-ups.
ATC code R01 Nasal preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
It is the first asthma triple-combination therapy; it consists of a fixed-dose combination of three active substances (indacaterol, glycopyrronium bromide and mometasone furoate) in capsules, to be administered using an inhaler. [11] An optional electronic sensor may also be co-packed with the product. [11]
[1] [2] [3] It contains olopatadine hydrochloride and mometasone furoate monohydrate. [1] [2] It is sprayed into the nose. [1] [2] Common side effects include an unpleasant taste . [1] It was approved for medical use in Australia in December 2019, [1] [4] and in the United States in January 2022. [2]